|
Dr. Alkayed is a Professor of Anesthesiology and
Peri-Operative Medicine (APOM) at Oregon Health &
Science University (OHSU) and holds a joint
appointment in Physiology and Pharmacology. He is
Director of the newly formed Division of
Cerebrovascular Research and Associate Director of
the Research Center for Gender-Based Medicine at
OHSU. In addition, Dr. Alkayed serves on the Program
for Molecular and Cellular Biosciences (PMCB) and
the Neuroscience Graduate Program (NGP) at OHSU.
Dr. Alkayed is funded through an R01 grant from the
National Institute of Neurological Disease and
Stroke (NINDS) to study the role of P450 eicosanoids
and their metabolizing enzyme soluble epoxide
hydrolase in ischemic brain injury and blood flow
regulation in the brain. He is also funded through
an NINDS Program Project Grant (PPG) to investigate
the role of cocaine- and amphetamine-regulated
transcript (CART) and signal transducer and
activator of transcription-3 (STAT3) in
estrogen-mediated neuroprotection. Dr. Alkayed sits
on the editorial boards of Stroke, The
American Journal of Physiology–Heart and Circulation,
and the Journal of Cerebral Blood Flow and
Metabolism. He is a member of the American Heart
Association Brain and Stroke Study Section and the
National Institutes of Health Neural Oxidative
Metabolism and Death Study Section.
Dr.
Alkayed grew up in Amman, Jordan. He earned his
medical degree from Stavropol State Medical Academy
in Russia and a PhD in physiology from the Medical
College of Wisconsin in Milwaukee.
After completing a
postdoctoral research fellowship at Johns Hopkins
University, Dr. Alkayed launched his academic career
as Assistant Professor of Anesthesiology & Critical
Care Medicine at The Johns Hopkins School of
Medicine in 1998. He joined OHSU in 2003 as
Associate Professor, and in 2008, he was promoted to
Professor. |
